Kura Oncology (KURA) Tops Q4 EPS by 8c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.49), $0.08 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• Cintas beats estimates but stock edges lower
• Activist Jana Partners calls for Six Flags sale - WSJ